An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

Cited by (212)

Items 101–200 of 212

1. mRNA Vaccine Designing Using Chikungunya Virus E Glycoprotein through Immunoinformatics-Guided Approaches
   Samavia Jaan, Aqal Zaman, Sarfraz Ahmed · 2022 · Vaccines
2. Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]
   Vijayakumar Jawalagatti, Perumalraja Kirthika, John Hwa Lee · 2022 · Frontiers in Immunology
3. Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults
   Jesse C. Nussbaum, Xin Cao, Radha A. Railkar, Jeffrey R. Sachs, Daniel S. Spellman, Julie Ann Mabalot Luk, Christine A. Shaw, Pedro Joel Cejas, Michael P. Citron, Mohamed S Al-Ibrahim et al. · 2023 · Vaccine
4. Deciphering the Immunogenicity of Monkeypox Proteins for Designing the Potential mRNA Vaccine
   Mohibullah Shah, Samavia Jaan, Muhammad Shehroz, Asifa Sarfraz, Khamna Asad, Tehreem Ul Wara, Aqal Zaman, Riaz Ullah, Essam A. Ali, Umar Nishan et al. · 2023 · ACS Omega
5. Nanoparticle-based delivery platforms for mRNA vaccine development
   Sezer Okay, Öznur Özge Özcan, Mesut Karahan · 2020 · AIMS Biophysics
6. Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine
   Ivan V. Kuzmin, Rubén Soto-Acosta, Layne Pruitt, Perry T. Wasdin, Kritika Kedarinath, Keziah R. Hernandez, Kristyn A. Gonzales, Kharighan Hill, Nicole G. Weidner, Chad E. Mire et al. · 2024 · Nature Communications
7. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice
   Jie Liu, Jie Sun, Xue Ding, Wenhao Liu, Yipeng Wang, Zihan Wang, Hanyu Peng, Yong Zhang, Weiheng Su, Chunlai Jiang · 2024 · Emerging Microbes & Infections
8. mRNA delivery technologies: Toward clinical translation
   Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Alicia Rodríguez‐Gascón, Ana del Pozo‐Rodríguez, Maria Ángelés Solinís · 2022 · International review of cytology
9. Development of an RNA Expression Platform Controlled by Viral Internal Ribosome Entry Sites
   Hae Li Ko, Hyo‐Jung Park, Jihye Kim, Heon Kim, Hyewon Youn, Jae‐Hwan Nam · 2019 · Journal of Microbiology and Biotechnology
10. Infectious RNA vaccine protects mice against chikungunya virus infection
    Inga Szurgot, Karl Ljungberg, Beate Mareike Kümmerer, Peter Liljeström · 2020 · Scientific Reports
11. SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development
    Iqra Mehmood, Munazza Ijaz, Sajjad Ahmad, Temoor Ahmed, Amna Bari, Asma Abro, Khaled S. Allemailem, Ahmad Almatroudi, Muhammad Tahir ul Qamar · 2021 · International Journal of Environmental Research and Public Health
12. Early approval of COVID-19 vaccines: Pros and cons
    Md Arifur Rahman, Md Sayeedul Islam · 2021 · Human Vaccines & Immunotherapeutics
13. An mRNA vaccine against rabies provides strong and durable protection in mice
    Miao Li, Enyue Fang, Yunpeng Wang, Leitai Shi, Jia Li, Qinhua Peng, Xingxing Li, Danhua Zhao, Xiaohui Liu, Xinyu Liu et al. · 2023 · Frontiers in Immunology
14. Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice
    M. Allison Wolf, Joanne M. O’Hara, Graham J. Bitzer, Elisabeth Narayanan, Dylan T. Boehm, Justin R. Bevere, Megan A. DeJong, Jesse M. Hall, Ting Y. Wong, Samantha Falcone et al. · 2024 · npj Vaccines
15. Profile of Katalin Karikó and Drew Weissman: 2023 Nobel laureates in Physiology or Medicine
    Florian Krammer, Peter Palese · 2024 · Proceedings of the National Academy of Sciences
16. Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs
    Miriam Pedrera, Rebecca K. McLean, Lobna Medfai, Nazia Thakur, Shawn Todd, Glenn Marsh, Dalan Bailey, Gaetano Donofrío, Hiromi Muramatsu, Norbert Pardi et al. · 2024 · Frontiers in Immunology
17. A Comprehensive Review of Our Understanding and Challenges of Viral Vaccines against Swine Pathogens
    Aman Kamboj, Shaurya Dumka, Mumtesh Kumar Saxena, Yashpal Singh, Bani Preet Kaur, Severino Jefferson Ribeiro da Silva, Sachin Kumar · 2024 · Viruses
18. Optimised non-coding regions of mRNA SARS-CoV-2 vaccine CV2CoV improves homogeneous and heterogenous neutralising antibody responses
    Roth, Nicole, Schön, Jacob, Hoffmann, Donata, Thran, Moritz, Thess, Andreas, Mueller, Stefan O., Petsch, Benjamin, Rauch, Susanne · 2021
19. IL-7 promotes mRNA vaccine-induced long-term immunity
    Lingli Wang, Jiawu Wan, Wenna He, Zongmei Wang, Qiong Di Wu, Ming Zhou, Zhen Fang Fu, Ling Zhao · 2024 · Journal of Nanobiotechnology
20. Emerging mRNA Technology for Liver Disease Therapy
    Ji Wang, Yile Fang, Zhiqiang Luo, Jinglin Wang, Yuanjin Zhao · 2024 · ACS Nano
21. Advancement in the development of mRNA ‐based vaccines for respiratory viruses
    Tays Troncoso‐Bravo, Mario A. Ramírez, Ricardo A. Loaiza, Carolina Román-Cárdenas, Georgios Papazisis, Daniel A. Garrido, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis · 2024 · Immunology
22. Enhancing immune function and fish health in aquaculture
    Manuel Soto‐Dávila, Maureen Frances Latimer, Brian Dixon · 2020 · Fish physiology
23. Recent Advances in Arboviral Vaccines: Emerging Platforms and Promising Innovations
    Sujit Kumar Pujhari · 2023 · Biologics
24. Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
    Xiao Guo, Dongying Liu, Yukai Huang, Youcai Deng, Ying Wang, Jingrui Mao, Yuancheng Zhou, Yongai Xiong, Xinghong Gao · 2023 · Virology Journal
25. Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
    Wubetu Yihunie Belay, Getinet Nibret, Yibeltal Aschale · 2023 · Clinical Pharmacology Advances and Applications
26. A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques
    Ting Bian, Meng Hao, Xiaofan Zhao, Chuanyi Zhao, Gang Luo, Zhendong Zhang, Guangcheng Fu, Yang Lu, Yi Chen, Yudong Wang et al. · 2023 · npj Vaccines
27. Advances in Development of mRNA-Based Therapeutics
    Lei Huang, Luyao Zhang, Weiwei Li, Shiqiang Li, Jianguo Wen, Hangwen Li, Zhongmin Liu · 2020 · Current topics in microbiology and immunology
28. Rabies vaccine: Recent update and comprehensive review of in vitro and in vivo studies
    Maliheh Abedi, Saeed Mohammadian Haftcheshmeh, Rouzbeh Bashar, Prashant Kesharwani, Morteza Samadi, Amirhossein Sahebkar · 2022 · Process Biochemistry
29. Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C
    Federico Napolitano, Rossella Merone, Adele Abbate, Virginia Ammendola, Emma Horncastle, Francesca Lanzaro, Marialuisa Esposito, Alessandra Maria Contino, Roberta Sbrocchi, Andrea Sommella et al. · 2021 · PLoS neglected tropical diseases
30. Development of mRNA rabies vaccines
    Zixin Fang, Pengcheng Yu, Wuyang Zhu · 2024 · Human Vaccines & Immunotherapeutics
31. A Regimen Compression Strategy for Commercial Vaccines Leveraging an Injectable Hydrogel Depot Technology for Sustained Vaccine Exposure
    Jerry Yan, Ben S. Ou, Olivia M. Saouaf, Emily L. Meany, Noah Eckman, Eric Andrew Appel · 2023 · Advanced Therapeutics
32. A rabies mRNA vaccine provides a rapid and long-term immune response in mice
    Jinrong Long, Changxiao Yu, Yiming Cao, Yiqi Miao, Huisheng Sun, Zhen Zhang, Jierui Mai, Xin Wang, Yingying Mao, Hongwei Li et al. · 2023 · Nano Today
33. Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization
    Dongdong Li, Xuan Wang, Gaotian Li, Jingying Zhou, Lijun Bian, Xiaoyan Zhao, Liao Xing, Juanmei Zeng, Jiaxing Cui, Lili Cui et al. · 2025 · npj Vaccines
34. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector
    Maryann Giel–Moloney, Alexander A. Rumyantsev, Fred David · 2017 · Vaccine
35. Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses
    Jarin Taslem Mourosi, Ayobami Awe, Swati Jain, Himanshu Batra · 2022 · Vaccines
36. The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize
    Mirosław Janowski, Anna Andrzejewska · 2022 · Molecular Therapy — Nucleic Acids
37. circDesign Algorithm for Designing Synthetic Circular RNA
    Congcong Xu, Chengtao Pu, Ruofan Chen, Weiyun Wang, Fan Jiang, Changchang Deng, Dongqing Zhai, Yuenan Chen, Weiwei Hu, Yuting Zhang et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
38. Research progress of mRNA vaccines for infectious diseases
    Zhen Zhang, Jingli Du, Danyang Zhang, Rui Han, Xueqiong Wu, Yan Liang · 2025 · European journal of medical research
39. Forensic analysis of the 38 subject deaths in the 6-Month Interim Report of the Pfizer/BioNTech BNT162b2 mRNA Vaccine Clinical Trial
    Corinne A. Michels, Daniel Perrier, Jeyanthi Kunadhasan, Ed Clark, Joseph Gehrett, Barbara Gehrett, Kim Kwiatek, Sarah Adams, Robert W. Chandler, Leah Stagno et al. · 2023 · International Journal of Vaccine Theory Practice and Research
40. Vaccine Molecule Design Based on Phage Display and Computational Modeling against Rhabdovirus
    Yuying Zheng, Liang Zhao, Xuefeng Wei, Tian-Zi Sun, Feifan Xu, Gao‐Xue Wang, Bin Zhu · 2024 · The Journal of Immunology
41. Enzymatic Protein Biopolymers as a Tool to Synthetize Eukaryotic Messenger Ribonucleic Acid (mRNA) with Uses in Vaccination, Immunotherapy and Nanotechnology
    Fabiola Urbina, Sebastián Morales, Edio Maldonado · 2020 · Polymers
42. A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs
    Yuan Zhang, Lingying Fang, Zongmei Wang, Chengguang Zhang, Jianqing Zhao, Hakimeh Baghaei Daemi, Mai Zhang, Liwen Yuan, Xiaohu Han, Linfeng Li et al. · 2024 · Emerging Microbes & Infections
43. Interferon Inhibition Enhances the Pilot-Scale Production of Rabies Virus in Human Diploid MRC-5 Cells
    Xiao Yang, Mingming Wan, Linjun Cai, Ali Hou, Bo Sun, Yan Zhou, Feng Gao, Weiheng Su, Chunlai Jiang · 2021 · Viruses
44. Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates
    Neeltje van Doremalen, Robert J. Fischer, Jonathan E. Schulz, Myndi G. Holbrook, Brian J. Smith, Jamie Lovaglio, Benjamin Petsch, Vincent Jacobus Munster · 2021 · Viruses
45. mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic
    Peixian Chen, Xiaoye Shi, Weixin He, Guowei Zhong, Yan Tang, Hailin Wang, Peidong Zhang · 2022 · Human Vaccines & Immunotherapeutics
46. mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19
    Christina M. Kackos, Sherri L. Surman, Bart G. Jones, Robert E. Sealy, Trushar Jeevan, Christopher J.H. Davitt, Sergei Pustylnikov, Tamarand L. Darling, Adrianus C. M. Boon, Julia L. Hurwitz et al. · 2023 · Microbiology Spectrum
47. Optimization of Non-Coding Regions Improves Protective Efficacy of an mRNA SARS-CoV-2 Vaccine in Nonhuman Primates
    Gebre, Makda S., Rauch, Susanne, Roth, Nicole, Yu, Jingyou, Chandrashekar, Abishek, Mercado, Noe B., He, Xuan, Liu, Jinyan, McMahan, Katherine, Martinot, Amanda et al. · 2021
48. mRNA vaccines against infectious diseases and future direction
    Muhammad Tahir Aleem, Furqan Munir, Amna Shakoor, Fenfei Gao · 2024 · International Immunopharmacology
49. A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database
    Hassan Hussein Musa, Taha Hussein Musa · 2022 · Human Vaccines & Immunotherapeutics
50. A nucleoside-modified rabies mRNA vaccine induces long-lasting and comprehensive immune responses in mice and non-human primates
    Yu Wang, Shen Wang, Lulu Huang, Wenhao Mao, Fangmeng Li, Ang Lin, Weijun Zhao, Xianhuan Zeng, Yue Zhang, Dingcao Yang et al. · 2024 · Molecular Therapy
51. Recent and advanced nano-technological strategies for COVID-19 vaccine development
    Chinekwu Sherridan Nwagwu, Chinenye Nnenna Ugwu, John Dike Ogbonna, Adaeze Linda Onugwu, Chinazom Precious Agbo, Adaeze Chidiebere Echezona, Ezinwanne Nneoma Ezeibe, Samuel Wisdom Uzondu, Franklin Chimaobi Kenechukwu, Paul Achile Akpa et al. · 2022 · Methods in microbiology
52. Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development
    Yaru Jia, Ziran Zhou, Luksika Jiramonai, Jianxin Chen, Qian Hua, Mengliang Zhu, Jinchao Zhang, Xing‐Jie Liang · 2025 · Coordination Chemistry Reviews
53. Harnessing nucleic acid technologies for human health on earth and in space
    Samantha L. Sarli, Jonathan K. Watts · 2022 · Life Sciences in Space Research
54. Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review
    Christine M. Akamine, Hana M. El Sahly · 2021 · Translational research
55. Advances in mRNA vaccines for viral diseases
    Yukai Huang, Xuerui Zhu, Xiao Guo, Yuancheng Zhou, Dongying Liu, Jingrui Mao, Yongai Xiong, Youcai Deng, Xinghong Gao · 2023 · Journal of Medical Virology
56. Rabies vaccination induces a CD4+ TEM and CD4+CD8+ TEMRA TH1 phenotype in dogs
    Haeree Park, Farah F. Almeer, Marc K. Jenkins · 2025 · PLoS ONE
57. Pre-clinical evaluation of mRNA-lipid nanoparticles’ potency and toxicity: current practices and future directions
    Chloé Muzard, Johanne Séguin, Jonathan Bonnefoy, Nahla Salkini, Vincent A. Serra, Khair Alhareth, Katia Lemdani, Nathalie Mignet · 2025 · In vitro models
58. Potential option for rabies post-exposure prophylaxis: New vaccine with PIKA adjuvant against diverse Chinese rabies strains
    Pengcheng Yu, Yuan Liu, Xiaoyan Tao et al. · 2023 · Vaccine
59. Vaccines: An overview
    Santiago M. C. Lopez, Alice I. Sato, Archana Chatterjee · 2023 · Elsevier eBooks
60. Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study
    Netanella Danielli Miller, Nitzan Goren Gepstein, Dovev Cohen, Einat Haikin Herzberger, Hila Shalev Ram, Jordana Mashiach Friedler, Maya Sharon‐Weiner, Roni Rahav, Victoria Indenbaum, Yaniv Lustig et al. · 2024 · Clinical and Experimental Medicine
61. Introduction to RNA Vaccines Post COVID-19
    Thomas Kramps · 2024 · Methods in molecular biology
62. Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice
    Shimeng Bai, Xinghao Pan, Tianhan Yang, Nan Gao, Cuisong Zhu, Ai Xia, Meiqi Feng, Miaomiao Zhang, Xiaoyan Zhang, Jianqing Xu · 2025 · Communications Medicine
63. Updates on the development of vaccines and therapeutic options against rabies
    Roshan Arjun Ananda, Hooi‐Leng Ser, Vengadesh Letchumanan · 2020 · Progress In Microbes & Molecular Biology
64. mRNA Vaccine Development in the Fight Against Zoonotic Viral Diseases
    Brandon E. K. Tan, Seng Kong Tham, Chit Laa Poh · 2025 · Viruses
65. Immunogenicity and efficacy of an LNP-mRNA prepared from African swine fever virus K205R
    Chuanwen Tian, Yingnan Liu, Dongdong Di · 2024 · Journal of Integrative Agriculture
66. Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses
    Rafid Jihad Albadr, Hayder Naji Sameer, Zainab H. Athab, Mohaned Adil, Ahmed Yaseen, Omer Qutaiba B. Allela · 2025 · Biological Procedures Online
67. Vaccine types and reverse vaccinology
    Angus Nnamdi Oli, Adekunle Babajide Rowaiye · 2022 · Elsevier eBooks
68. Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound
    Robert Were Omange, Benjamin D. Varco-Merth, O. Fadeyi, Alejandra Marenco, Hiroshi Takata, Derick M. Duell, William Douglass Goodwin, Paula Armitage, Christine M. Fennessey, Emek Köse et al. · 2026 · Journal of Clinical Investigation
69. mRNA vaccines transform personalized lung cancer treatment
    Kaiqi Wei, Zitong Wan, Miaomiao Wen, Shaowei Xin, Yinxi Zhou, Jun Chao Wei, Jianfei Zhu, Chengbin Tang, Yanlu Xiong, Tao Jiang et al. · 2026 · Frontiers in Immunology
70. Rabies and Related Lyssaviruses
    Charles E. Rupprecht, Rachel Kerina Chikwamba · 2018 · Springer eBooks
71. A VSV-based oral rabies vaccine was sentineled by Peyer’s patches and induced a timely and durable immune response
    Shen Wang, Zhenshan Wang, Weiqi Wang, Hongyu Sun, Na Feng, Yongkun Zhao, Jianzhong Wang, Tiecheng Wang, Xianzhu Xia, Feihu Yan · 2025 · Molecular Therapy
72. Isolation of Rabies Virus Glycoprotein Using Three-Phase Extraction and Characteristics of its Antigenic Properties
    Marina A. Efimova, Ахмадеев Рафаил Мазитович, Antonina G. Galeeva · 2022 · Problems of Particularly Dangerous Infections
73. RNA vaccines in infectious diseases: A systematic review
    Emília de Freitas Beirigo, Pablo Igor Ribeiro Franco, José Rodrigues do Carmo Neto, Rhanoica Oliveira Guerra, Thaís Soares Farnesi-de-Assunção, Isabella de Oliveira Ferrato Sousa, Malú Mateus Santos Obata, Wellington Francisco Rodrigues, Juliana Reis Machado, Marcos Vinicius da Silva · 2023 · Microbial Pathogenesis
74. Innovation in the 21st century: following the footsteps of Katalin Karikó
    Csaba Deák, Norbert Pardi, Ádám Miklósi · 2023 · Biologia Futura
75. Abordagens integrativas em Ciências da Saúde e comportamento humano
    Taísa Kelly Pereira da Silva · 2024
76. Nonclinical safety and biodistribution evaluation of HC009 mRNA vaccine against COVID-19 in rat
    Juan Liu, Xicheng Chen, Chuanqian Chen, Jie Wu, Fengyang Xie, Jing Li, Huafeng Han, Yingying Zhao, Yongsheng Yang · 2025 · Toxicology
77. Immunogenicity and Antigenicity of the Recombinant Ectodomain of Rabies Virus Glycoprotein Containing the Human Collagen XVIII Trimerization Domain
    Izat Smekenov, G.A. Bayandy, Sanzhar Alybayev · 2025 · Vaccines
78. mRNA Based Vaccine Studies in Infectious Diseases and Current Developments
    Ümit Savaşçı, Hanefi Cem Gül · 2021 · Journal of Molecular Virology and Immunology
79. Nanotechnology in vaccines and personalized medicine
    Marli S.P. Azevedo, Anil K. Patri · 2023 · Elsevier eBooks
80. RNA therapeutics for infectious diseases
    Le Minh Tu Phan; Phan Le Minh Tu, Thi Thuy Duong Pham, Van Thai Than · 2024 · Progress in molecular biology and translational science
81. Vacinas de RNA mensageiro: da Revolução tecnológica à eficácia no controle da pandemia de COVID-19
    Ellen Cristina Silva, Daniela Santos Pontes · 2024
82. Is there a future for mRNAs as viral vaccines?
    Mary J. Warrell · 2017 · The Lancet
83. mRNA疗法的研究进展与挑战
    Jiayan Fu, Shuo Feng, Binhe Du, Haiyang Dong, Jinzhong Lin, Jin Yongfeng · 2021 · Scientia Sinica Vitae
84. Next generation of rabies vaccines
    Hildegund C.J. Ertl · 2020 · Elsevier eBooks
85. Rabies
    Charles E. Rupprecht, Donna M. Gatewood · 2021
86. New Challenges In Non-Linear Signal And Image Processing
    Stephen Marshall, Edward R. Dougherty · 2004
87. New vaccines on the horizon
    Nevena Arsenović-Ranin · 2019 · Arhiv za farmaciju
88. Novel Rabies Vaccines
    Hildegund C.J. Ertl · 2020 · Springer eBooks
89. mRNA Vaccine: An Advanced and Transformative Technology for Vaccine Development
    Vikas Kushwaha, Anuprabha, R.C. Sobti · 2021 · Springer eBooks
90. Combating rabies: Current perspective
    Aakanksha Tiwari, Rajesh Kumar · 2022 · Indian Journal of Comparative Microbiology Immunology and Infectious Diseases
91. Biotechnology applications in infectious disease
    Kenneth H. Lundstrom · 2022 · Elsevier eBooks
92. Messenger RNA Therapeutics: Start of a New Era in Medicine
    Saloni Jain, Abhilash J. George, Vasu Sharma, Gagandeep Singh, Vandana Gupta · 2022 · RNA technologies
93. A REVIEW ON ADVANCES AND CHALLENGES IN DEVELOPMENT OF MRNA-BASED VACCINES
    Sahar Akbarizadeh-Khajeh, Ali Farhadi Biregani, Abbas Doosti · 2022 · Studies in Medical Sciences
94. The production of mRNA vaccines in the COVID-19 pandemic: advent of new applications in health treatments
    Ana Luiza Marques de Miranda Silva, Ana Paula Sales De Araújo, Vitor Hugo Auzier Lima, Ciane Martins de Oliveira · 2023 · Brazilian Journal of Health Review
95. No-One Left Behind: A Holistic Approach
    Fingani Annie Mphande · 2023 · Sustainable development goals series
96. It’s Worth a Shot
    Kristin Ambrose · 2023 · The Science Teacher
97. Mechanism, applications and of mRNA vaccines
    Chuci Wang · 2023 · Highlights in Science Engineering and Technology
98. mRNA vaccines: the next frontier in disease prevention
    Quratul ain Babar, Maryam Maryam, ALI MUSTAPHA MUHAMMAD, Muhammad Farrukh Tahir, Anwar Mohamed Ali · 2024 · Elsevier eBooks
99. mRNA vaccines: The new frontier
    Zhipeng Yan, Ming Jin Yang, Elaine Tian, Ching‐Lung Lai · 2025 · Elsevier eBooks
100. Peptide and m-RNA Vaccines: Peculiarities of Immunogenicity and Protective Effect
     Tatyana F. Stepanova, Olga Evgenevna Trotsenko, I. V. Bakshtanovskaya, Базыкина Елена Анатольевна, Kseniya B. Stepanova · 2025 · Epidemiology and Vaccinal Prevention